Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.644 SEK | -5.29% | -48.06% | -83.88% |
May. 15 | Transcript : Scandion Oncology A/S - Special Call | |
Mar. 21 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
- Stock Market
- Equities
- SCOL Stock
- News Scandion Oncology A/S
- MarketScreener Editorial Features